Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydroxocobalamin 3mg/5ml oral liquid
0901020N0AAAGAG
|
Hydroxocobalamin | Hydroxocobalamin | Nutrition and Blood | No data available |
|
Hydroxyapatite 3.32g granules sachets sugar free
0905011Z0AAADAD
|
Hydroxyapatite | Hydroxyapatite | Nutrition and Blood | No data available |
|
Hydroxyapatite 830mg tablets
0905011Z0AAACAC
|
Hydroxyapatite | Hydroxyapatite | Nutrition and Blood | No data available |
|
Hydroxycarbamide 300mg capsules
0801050P0AAACAC
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | No data available |
|
Hydroxychloroquine 108mg/5ml oral solution
1001030C0AABABA
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 120mg/5ml oral liquid
1001030C0AAAVAV
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 150mg/5ml oral liquid
1001030C0AAANAN
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 15mg/5ml oral solution
1001030C0AABCBC
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 160mg/5ml oral solution
1001030C0AAAPAP
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 20mg/5ml oral solution
1001030C0AAAKAK
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 22mg/5ml oral solution
1001030C0AAAUAU
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 250mg/5ml oral solution
1001030C0AABEBE
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 25mg/5ml oral solution
1001030C0AAASAS
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 30mg/5ml oral solution
1001030C0AAAMAM
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 36mg/5ml oral solution
1001030C0AABFBF
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 400mg/5ml oral solution
1001030C0AAAWAW
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 400mg/5ml oral suspension
1001030C0AABLBL
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 40mg/5ml oral solution
1001030C0AAAHAH
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 53.33mg/5ml oral solution
1001030C0AABDBD
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 60mg/5ml oral solution
1001030C0AAALAL
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 65mg/5ml oral solution
1001030C0AAAQAQ
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 70mg/5ml oral solution
1001030C0AAAZAZ
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 75mg/5ml oral liquid
1001030C0AAAGAG
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 80mg/5ml oral solution
1001030C0AABHBH
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 85mg/5ml oral solution
1001030C0AAAYAY
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.